FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicoletta Biglia

Research Profile

Disorders

Procedures

Physiology

Concepts & Ideas

Chemicals & Drugs

Living Beings

Survivors

Co-author Network

Publications

TOP 3
Nicoletta Biglia; V E Bounous; M D'Alonzo; V Liberale; Furio Maggiorotto; S Pecchio; Luca Sgro; Riccardo Ponzone
Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Daniela Cimino; Christian Damasco; Michele De Bortoli; Cristiano De Pitta; Marco Forni; Gerolamo Lanfranchi; Francesca Orso; Elisa Penna; Eva Pinatel; Riccardo Ponzone; Paolo Provero; Elena Quaglino; Chiara Romualdi; Nicoletta Biglia; Cathrin Brisken; Silvia Casara; Matteo Zampini; Daniela Taverna
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.
Nicoletta Biglia; Furio Maggiorotto; Giulia Moggio; Elisa Peano; Silvia Pecchio; Paola Sgandurra; Piero Sismondi
Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicoletta Biglia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nicoletta Biglia; V E Bounous; M D'Alonzo; V Liberale; Furio Maggiorotto; S Pecchio; Luca Sgro; Riccardo Ponzone
Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2013;39(5):455-60.
2013: Daniela Cimino; Christian Damasco; Michele De Bortoli; Cristiano De Pitta; Marco Forni; Gerolamo Lanfranchi; Francesca Orso; Elisa Penna; Eva Pinatel; Riccardo Ponzone; Paolo Provero; Elena Quaglino; Chiara Romualdi; Nicoletta Biglia; Cathrin Brisken; Silvia Casara; Matteo Zampini; Daniela Taverna
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(3):1223-35.
2013: Nicoletta Biglia; Furio Maggiorotto; Giulia Moggio; Elisa Peano; Silvia Pecchio; Paola Sgandurra; Piero Sismondi
Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2013;29(3):263-7.
2013: Daniele Recupero; Alberto Righi; Mauro Risio; Nicoletta Biglia; Paola Cassoni; Isabella Castellano; Lorenzo Daniele; Caterina Marchiò; Luca Molinaro; Filippo Montemurro; Piero Sismondi; Giuseppe Viale; Anna Sapino
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
The Journal of pathology 2013;229(3):390-9.
2012: Marta D'Alonzo; Franziska Kubatzki; Furio Maggiorotto; Laura Martincich; Filippo Montemurro; Alberto Pisacane; Giovanni De Rosa; Piero Sismondi; Nicoletta Biglia; Riccardo Ponzone
Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2012;48(15):2311-8.
2012: Annamaria Ferrero; Lucia Ricci Maccarini; Federica Pozzati; Martina Rossi; Isabella Strada; Nicoletta Biglia; Barbara Di Marcoberardino; Pierandrea De Iaco
Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(7):1158-62.
2012: Carlo Campagnoli; Raffaella Colombero; Saverio Danese; Michela Donadio; Patrizia Pasanisi; Elisabetta Venturelli; Gianna Zito; Chiara Abbà; Simona Ambroggio; Nicoletta Biglia; Tiziana Brucato; Franco Berrino
Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
Clinical breast cancer 2012;12(3):175-82.
2012: Annalisa Lorenzato; Cosimo Martino; Yvonne Oligschläger; Martina Olivero; Nicoletta Biglia; Raffaele Calogero; Nadia Dani; Anna Maria Ferrero; Maria Flavia Di Renzo
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(6):2446-56.
2012: Lorenzo Ferraro; Olivier Friard; Giorgio Giurato; Giovanni Nassa; E Nola; Maria Ravo; Francesca Rizzo; Silvana Silvestro; Claudia Stellato; Roberta Tarallo; Nicoletta Biglia; Concita Cantarella; Luigi Cicatiello; Daniela Cimino; Francesca Cirillo; Michele De Bortoli; Maria Rosaria De Filippo; Alessandro Weisz
Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells.
Hormones & cancer 2012;3(3):65-78.
2011: Piero Sismondi; Nicoletta Biglia; Jan Egberts; Rainer Kimmig; Ernst Kubista; Giulia Moggio; Mirjam Mol-Arts; Roel Mulder; Juan Planellas; Peter Kenemans
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Maturitas 2011;70(4):365-72.
2011: Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Rocca; Emanuela Scarpi; Francesco Schittulli; Mario Brandi; Roberta Maltoni; Patrizia Serra; Riccardo Ponzone; Nicoletta Biglia; Lorenzo Gianni; Amelia Tienghi; Maria Rosaria Valerio; Paola Bonginelli; Laura Amaducci; Marina Faedi; Editta Baldini; angelo paradiso
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast cancer research and treatment 2011;125(3):775-84.
2010: Nicoletta Biglia; Silvia Maffei; Stefano Lello; Rossella E Nappi
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2010;26(11):804-14.
2010: Angiolo Gadducci; Nicoletta Biglia; Stefania Cosio; Piero Sismondi; Andrea Riccardo Genazzani
Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2010;26(8):568-77.
2010: Nicoletta Biglia; Elisa Peano; Paola Sgandurra; Giulia Moggio; Enrico Panuccio; Marco Migliardi; Nicoletta Ravarino; Riccardo Ponzone; Piero Sismondi
Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2010;26(6):404-12.
2010: Nicoletta Biglia; Giulia Moggio; Elisa Peano; Paola Sgandurra; Riccardo Ponzone; Rossella E Nappi; Piero Sismondi
Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
The journal of sexual medicine 2010;7(5):1891-900.
2009: Angiolo Gadducci; Nicoletta Biglia; Stefania Cosio; Piero Sismondi; Andrea Riccardo Genazzani
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009;25(12):807-15.
2009: Riccardo Ponzone; Nicoletta Tomasi Cont; Furio Maggiorotto; Elisa Cassina; Paola Mininanni; Nicoletta Biglia; Piero Sismondi
Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5547-51.
2009: Nicoletta Biglia; P Sgandurra; E Peano; Davide Marenco; G Moggio; V Bounous; N Tomasi Cont; Riccardo Ponzone; Piero Sismondi
Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
Climacteric : the journal of the International Menopause Society 2009;12(4):310-8.
2009: Riccardo Ponzone; E Cassina; N Tomasi Cont; Nicoletta Biglia; Piero Sismondi
Decreasing arm morbidity by refining axillary surgery in breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(4):335-8.
2008: Daniela Cimino; Luca Fuso; Christian Sfiligoi; Nicoletta Biglia; Riccardo Ponzone; Furio Maggiorotto; Giandomenico Russo; Luigi Cicatiello; Alessandro Weisz; Daniela Taverna; Piero Sismondi; Michele De Bortoli
Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.
International journal of cancer. Journal international du cancer 2008;123(6):1327-38.
2008: Nicoletta Biglia; L Mariani; Riccardo Ponzone; Piero Sismondi
Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
Maturitas 2008;60(2):71-7.
2008: Maria Silvia Giretti; fu xiaodong; Giovanni De Rosa; Ivana Sarotto; Chiara Baldacci; Silvia Garibaldi; Paolo Mannella; Nicoletta Biglia; Piero Sismondi; Andrea Riccardo Genazzani; Tommaso Simoncini
Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
PloS one 2008;3(5):e2238.
2007: Riccardo Ponzone; Annelise Dominguez; Vincenzo Marra; Alberto Pisacane; Furio Maggiorotto; Maria Elena Jacomuzzi; Alessandra Magistris; Nicoletta Biglia; Piero Sismondi
Pathological classification of ductal carcinoma in situ of the breast correlates with surgical treatment and may be predicted by mammography.
Breast (Edinburgh, Scotland) 2007;16(5):495-502.
2007: Nicoletta Biglia; Luca Mariani; Luca Sgro; Paola Mininanni; Giulia Moggio; Piero Sismondi
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Endocrine-related cancer 2007;14(3):549-67.
2007: Nicoletta Biglia; Franziska Kubatzki; Paola Sgandurra; Riccardo Ponzone; Davide Marenco; Elisa Peano; Piero Sismondi
Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial.
The breast journal 2007;13(5):490-5.
2007: Riccardo Ponzone; Furio Maggiorotto; Luca Mariani; Maria Elena Jacomuzzi; Alessandra Magistris; Paola Mininanni; Nicoletta Biglia; Piero Sismondi
Comparison of two models for the prediction of nonsentinel node metastases in breast cancer.
American journal of surgery 2007;193(6):686-92.
2007: Piero Sismondi; Nicoletta Biglia; Riccardo Ponzone; Luca Fuso; Claudio Scafoglio; Luigi Cicatiello; Maria Ravo; Alessandro Weisz; Daniela Cimino; Gioia Altobelli; Olivier Friard; Michele De Bortoli
Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.
Maturitas 2007;57(1):50-5.
2006: Riccardo Ponzone; Nicoletta Biglia; Maria Elena Jacomuzzi; Luca Mariani; Annelise Dominguez; Piero Sismondi
Antihormones in prevention and treatment of breast cancer.
Annals of the New York Academy of Sciences 2006;1089():143-58.
2006: Riccardo Ponzone; Filippo Montemurro; Furio Maggiorotto; Claudio Robba; Dario Gregori; Maria Elena Jacomuzzi; Franziska Kubatzki; Davide Marenco; Annelise Dominguez; Nicoletta Biglia; Piero Sismondi
Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1631-6.
2006: Claudio Scafoglio; Concetta Ambrosino; Luigi Cicatiello; Lucia Altucci; Mario Ardovino; Paola Bontempo; Nicola Medici; Anna Maria Molinari; Angela Nebbioso; Angelo Facchiano; Raffaele A Calogero; Ran Elkon; Nadia Menini; Riccardo Ponzone; Nicoletta Biglia; Piero Sismondi; Michele De Bortoli; Alessandro Weisz
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.
Journal of cellular biochemistry 2006;98(5):1163-84.
2006: Nicoletta Biglia; Ester Ujcic; Franziska Kubatzki; Paola Sgandurra; Claudio Robba; Riccardo Ponzone; Piero Sismondi
Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial.
Maturitas 2006;54(2):181-92.
2006: Nicoletta Biglia; Luca Mariani; Davide Marenco; Claudio Robba; Elisa Peano; Franziska Kubatzki; Piero Sismondi
Hormonal replacement therapy after gynaecological cancer.
Gynäkologisch-geburtshilfliche Rundschau 2006;46(4):191-6.
2005: Riccardo Ponzone; Nicoletta Biglia; Maria Elena Jacomuzzi; Furio Maggiorotto; Luca Mariani; Piero Sismondi
Vaginal oestrogen therapy after breast cancer: is it safe?
European journal of cancer (Oxford, England : 1990) 2005;41(17):2673-81.
2005: Nicoletta Biglia; Riccardo Torta; Riccardo Roagna; Furio Maggiorotto; Franca Cacciari; Riccardo Ponzone; Franziska Kubatzki; Piero Sismondi
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
Maturitas 2005;52(1):78-85.
2005: Angiolo Gadducci; Nicoletta Biglia; Piero Sismondi; Andrea R Genazzani
Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2005;20(6):343-60.
2005: Nicoletta Biglia; Luca Sgro; Enza DeFabiani; G De Rosa; Riccardo Ponzone; Davide Marenco; Piero Sismondi
The influence of hormone replacement therapy on the pathology of breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(5):467-72.
2005: Filippo Montemurro; Laura Martincich; Giovanni De Rosa; Stefano Cirillo; Vincenzo Marra; Nicoletta Biglia; Marco Gatti; Piero Sismondi; Massimo Aglietta; Daniele Regge
Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer.
European radiology 2005;15(6):1224-33.
2004: Nicoletta Biglia; Angiolo Gadducci; Riccardo Ponzone; Riccardo Roagna; Piero Sismondi
Hormone replacement therapy in cancer survivors.
Maturitas 2004;48(4):333-46.
2004: Riccardo Ponzone; Nicoletta Biglia; Piero Sismondi
Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Journal of the National Cancer Institute 2004;96(11):883-4; author reply 884-5.
2004: Luigi Cicatiello; Claudio Scafoglio; Lucia Altucci; Massimo Cancemi; Guido Natoli; Angelo Facchiano; Giovanni Iazzetti; Raffaele A Calogero; Nicoletta Biglia; Michele De Bortoli; Christian Sfiligoi; Piero Sismondi; Francesco Bresciani; Alessandro Weisz
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome.
Journal of molecular endocrinology 2004;32(3):719-75.
2004: Piero Sismondi; Nicoletta Biglia
HRT and gynaecologic cancer after WHI: old stuff or new doubts?
Maturitas 2004;48(1):13-8.
2004: Nicoletta Biglia; Marilena Cozzarella; Riccardo Ponzone; Davide Marenco; Furio Maggiorotto; Luca Fuso; Piero Sismondi
Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2004;18(3):165-74.
2004: Nicoletta Biglia; Enza DeFabiani; Riccardo Ponzone; Luca Mariani; Davide Marenco; Piero Sismondi
Management of risk of breast carcinoma in postmenopausal women.
Endocrine-related cancer 2004;11(1):69-83.
2004: Laura Martincich; Filippo Montemurro; Giovanni De Rosa; Vincenzo Marra; Riccardo Ponzone; Stefano Cirillo; Marco Gatti; Nicoletta Biglia; Ivana Sarotto; Piero Sismondi; Daniele Regge; Massimo Aglietta
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.
Breast cancer research and treatment 2004;83(1):67-76.
2003: Riccardo Ponzone; Nicoletta Biglia; Furio Maggiorotto; Franziska Kubatzki; O Elia; G De Rosa; Piero Sismondi
Sentinel node dissection as definitive treatment for node negative breast cancer patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(9):703-6.
2003: Nicoletta Biglia; Simona Ambroggio; Riccardo Ponzone; Luca Sgro; Ester Ujcic; Fabrizia Actis Dato; Piero Sismondi
Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens.
Maturitas 2003;45(4):283-91.
2003: Nicoletta Biglia; Marilena Cozzarella; Franca Cacciari; Riccardo Ponzone; Riccardo Roagna; Furio Maggiorotto; Piero Sismondi
Menopause after breast cancer: a survey on breast cancer survivors.
Maturitas 2003;45(1):29-38.
2003: V Sorbello; Luca Fuso; Christian Sfiligoi; Claudio Scafoglio; Riccardo Ponzone; Nicoletta Biglia; Alessandro Weisz; Piero Sismondi; Michele De Bortoli
Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer.
The International journal of biological markers 2003;18(2):123-9.
2003: George M Yousef; Andreas Scorilas; Terukazu Nakamura; Mohamed Abd Ellatif; Riccardo Ponzone; Nicoletta Biglia; Furio Maggiorotto; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Breast cancer research and treatment 2003;78(2):149-58.
2003: Christian Sfiligoi; Annarita de Luca; Ilaria Cascone; Valentina Sorbello; Luca Fuso; Riccardo Ponzone; Nicoletta Biglia; Enrica Audero; RICCARDO ARISIO; Federico Bussolino; Piero Sismondi; Michele De Bortoli
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival.
International journal of cancer. Journal international du cancer 2003;103(4):466-74.
2003: Piero Sismondi; Riccardo Ponzone; Nicoletta Biglia; Riccardo Roagna; Franca Cacciari; Furio Maggiorotto
Sentinel node biopsy for breast cancer: yes, less surgery is better surgery.
European journal of gynaecological oncology 2003;24(2):107-12.
2003: Nicoletta Biglia; Michele De Bortoli
Molecular characterization of breast cancer aggressiveness.
The International journal of biological markers 2003;18(1):36-9.
2002: George M Yousef; Andreas Scorilas; Angeliki Magklara; Nader Memari; Riccardo Ponzone; Piero Sismondi; Nicoletta Biglia; M Abd Ellatif; Eleftherios P Diamandis
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
British journal of cancer 2002;87(11):1294-300.
2002: George M Yousef; Carla A Borgoño; Andreas Scorilas; Riccardo Ponzone; Nicoletta Biglia; Lisa Iskander; Mary-Ellen Polymeris; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
British journal of cancer 2002;87(11):1287-93.
2002: George M Yousef; Andreas Scorilas; Lianna G Kyriakopoulou; Laura Rendl; Maria Diamandis; Riccardo Ponzone; Nicoletta Biglia; Maurizia Giai; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Clinical chemistry 2002;48(8):1241-50.
2001: Carlo Campagnoli; Chiara Abbà; Simona Ambroggio; Nicoletta Biglia; Riccardo Ponzone
Breast cancer and hormone replacement therapy: putting the risk into perspective.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2001;15 Suppl 6():53-60.
2001: Piero Sismondi; Nicoletta Biglia; Ester Ujcic; Riccardo Ponzone; Riccardo Roagna
Raloxifene and endometrial cancer.
Tumori 2001;87(5):S18-9.
2001: Erika Cottone; Francesca Orso; Nicoletta Biglia; Piero Sismondi; Michele De Bortoli
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity.
The International journal of biological markers 2001;16(3):151-66.
2000: Piero Sismondi; Nicoletta Biglia; Riccardo Roagna; Riccardo Ponzone; Simona Ambroggio; Luca Sgro; Marilena Cozzarella
How to manage the menopause following therapy for breast cancer. is raloxifene a safe alternative?
European journal of cancer (Oxford, England : 1990) 2000;36 Suppl 4():S74-6.
2000: V M De Benedetti; Nicoletta Biglia; Piero Sismondi; Michele De Bortoli
DNA chips: the future of biomarkers.
The International journal of biological markers 2000;15(1):1-9.
1999: Carlo Campagnoli; Nicoletta Biglia; C Cantamessa; L Lesca; Piero Sismondi
HRT and breast cancer risk: a clue for interpreting the available data.
Maturitas 1999;33(3):185-90.
1999: Carlo Campagnoli; Simona Ambroggio; Nicoletta Biglia; Piero Sismondi
Conjugated estrogens and breast cancer risk.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1999;13 Suppl 6():13-9.
1999: Piero Sismondi; Nicoletta Biglia; Maurizia Giai; Riccardo Ponzone; Riccardo Roagna; Luca Sgro; Carlo Campagnoli
HRT, breast and endometrial cancers: strategies and intervention options.
Maturitas 1999;32(3):131-9.
1998: Carlo Campagnoli; Simona Ambroggio; Nicoletta Biglia; Clementina Peris; Piero Sismondi
Insulin-like growth factor-I and risk of breast cancer.
Lancet 1998;352(9126):488-9.
1998: Carlo Campagnoli; Nicoletta Biglia; C Cantamessa; L Lesca; Marie Rosa Lotano; Piero Sismondi
Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1998;12(4):259-66.
1997: Carlo Campagnoli; Nicoletta Biglia; Maurizia Giai; Piero Sismondi
Progestins and breast cancer risk.
Zentralblatt für Gynäkologie 1997;119 Suppl 2():38-42.
1997: Carlo Campagnoli; Nicoletta Biglia; C Cantamessa; M M Di Sario; L Lesca
Effect of progestins on IGF-I serum level in estrogen-treated postmenopausal women.
Zentralblatt für Gynäkologie 1997;119 Suppl 2():7-11.
1996: Carlo Campagnoli; C Cantamessa; L Lesca; Piero Sismondi; Nicoletta Biglia
Misplaced confidences?
Fertility and sterility 1996;66(5):859-61.
1996: Adele Traina; R Cusimano; M Liquori; C Calabria; Nicoletta Biglia; Riccardo Ponzone; L Sgrò; Piero Sismondi
Oral contraceptive use and breast cancer risk in areas with different incidence. A case-control study among young women.
Annals of the New York Academy of Sciences 1996;784():564-9.
1996: Carlo Campagnoli; Nicoletta Biglia; Piero Sismondi
Hormone replacement therapy and breast cancer risk.
JAMA : the journal of the American Medical Association 1996;275(15):1159-60.
1996: Maurizia Giai; Riccardo Roagna; Riccardo Ponzone; Nicoletta Biglia; Luca Sgro; M Perona; Piero Sismondi
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
Anticancer research 1996;16(2):875-81.
1995: Piero Sismondi; Nicoletta Biglia
Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.
Pharmacological research : the official journal of the Italian Pharmacological Society 1995;32(6):329-30.
1995: Carlo Campagnoli; Nicoletta Biglia; C Peris; Piero Sismondi
Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1995;9(1):67-74.
1994: Piero Sismondi; Nicoletta Biglia; E Volpi; Maurizia Giai; T de Grandis
Tamoxifen and endometrial cancer.
Annals of the New York Academy of Sciences 1994;734():310-21.
1994: Piero Sismondi; Nicoletta Biglia; Maurizia Giai; Luca Sgro; Carlo Campagnoli
Metabolic effects of tamoxifen in postmenopause.
Anticancer research 1994;14(5B):2237-44.
1994: Carlo Campagnoli; Nicoletta Biglia; M G Lanza; L Lesca; C Peris; Piero Sismondi
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.
Maturitas 1994;19(1):25-31.
1994: Piero Sismondi; Nicoletta Biglia; Maurizia Giai; E Defabiani
GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000.
European journal of gynaecological oncology 1994;15(2):108-14.
1993: Carlo Campagnoli; Nicoletta Biglia; F Altare; M G Lanza; L Lesca; C Cantamessa; C Peris; G C Fiorucci; Piero Sismondi
Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1993;7(4):251-8.
1992: Carlo Campagnoli; M G Lanza; C Peris; Nicoletta Biglia; Piero Sismondi
Oral contraceptives and breast cancer.
Fertility and sterility 1992;58(6):1270-1; author reply 1272.
1992: Carlo Campagnoli; Nicoletta Biglia; P Belforte; D Botta; E Pedrini; Piero Sismondi
Post-menopausal breast cancer risk: oral estrogen treatment and abdominal obesity induce opposite changes in possibly important biological variables.
European journal of gynaecological oncology 1992;13(2):139-54.
1991: Nicoletta Biglia; Maurizia Giai; P Cortese; A Bottero; Piero Sismondi
[Postoperative infections and antibiotic prophylaxis in radical hysterectomy. Retrospective study].
Minerva ginecologica 1991;43(10):435-41.
1991: Nicoletta Biglia; Maurizia Giai; Piero Sismondi
[Postoperative infections and antibiotic prophylaxis in radical hysterectomy. Review of the literature].
Minerva ginecologica 1991;43(10):425-33.
1991: Maurizia Giai; Nicoletta Biglia; Piero Sismondi
Chemoresistance in breast tumors.
European journal of gynaecological oncology 1991;12(5):359-73.
1990: Maurizia Giai; Clara Natoli; Piero Sismondi; Nicoletta Biglia; G Lesti; M Mulieri; Stefano Iacobelli
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer.
Anticancer research 1990;10(1):119-21.
1990: Piero Sismondi; Maurizia Giai; E Defabiani; Nicoletta Biglia
Benign breast disease. An update.
Clinical and experimental obstetrics & gynecology 1990;17(2):53-116.
1988: G Saglio; C Camaschella; Maurizia Giai; A Serra; Angelo Guerrasio; B Peirone; P Gasparini; U Mazza; R Ceppellini; Nicoletta Biglia
Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population.
Breast cancer research and treatment 1988;11(2):147-53.